vbid/9781319200541

Description

Julien’s Primer of Drug Action continues to evolve side by side with the field it covers providing a thoroughly up to date look at psychotherapeutic and recreational drugs, including the latest research and the newest formulations.� � The thoroughly updated 14th edition features: � New coverage of opioids of abuse, and� drugs used to treat of opioid dependence and opioid overdose. New research on the use of marijuana to treat Alzheimers, PTSD,� and Epilepsy.�� New coverage of pharmacological, physiological, and psychoactive effects� of synthetic marijuana including its toxicity. New research on Cannabidiol (CBD) and its therapeutic uses New research of the efficacy of� antipsychotics to treat� dementia, Parkinson’s, bipolar, OCD, PTSD, New research on hallucinogenics for the treatment of various disorders including MDMA for the treatment of PTSD, Psilocybin for treatment of depression and end-of-life anxiety, and Ayahuasca to treat psychiatric disorders The use of genetic testing to predict effectiveness of� antidepressant treatment New research on the use of ketamine for the treatment of depressionTypham this is the title: Julien’s Primer of Drug Action 14th Edition